News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,963 Results
Type
Article (39772)
Company Profile (247)
Press Release (658944)
Multimedia
Podcasts (48)
Webinars (12)
Section
Business (204401)
Career Advice (2007)
Deals (35439)
Drug Delivery (95)
Drug Development (81066)
Employer Resources (172)
FDA (16249)
Job Trends (14873)
News (345577)
Policy (32580)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2561)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49472)
ALS (87)
Alzheimer's disease (1372)
Antibody-drug conjugate (ADC) (120)
Approvals (16250)
Artificial intelligence (245)
Autoimmune disease (21)
Automation (16)
Bankruptcy (361)
Best Places to Work (11651)
BIOSECURE Act (19)
Biosimilars (104)
Biotechnology (175)
Bladder cancer (63)
Brain cancer (26)
Breast cancer (270)
Cancer (2140)
Cardiovascular disease (170)
Career advice (1675)
Career pathing (30)
CAR-T (145)
Cell therapy (406)
Cervical cancer (19)
Clinical research (65921)
Collaboration (814)
Compensation (518)
Complete response letters (19)
COVID-19 (2585)
CRISPR (37)
C-suite (230)
Cystic fibrosis (100)
Data (2089)
Decentralized trials (2)
Denatured (18)
Depression (41)
Diabetes (262)
Diagnostics (6355)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (119)
Drug pricing (97)
Drug shortages (25)
Duchenne muscular dystrophy (92)
Earnings (86503)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (112217)
Executive appointments (705)
FDA (17455)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (738)
Gene editing (100)
Generative AI (19)
Gene therapy (286)
GLP-1 (703)
Government (4413)
Grass and pollen (4)
Guidances (51)
Healthcare (18856)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (111)
Indications (28)
Infectious disease (2725)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (92)
Interviews (311)
IPO (16504)
IRA (40)
Job creations (3634)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (462)
Leadership (16)
Legal (7925)
Liver cancer (72)
Lung cancer (310)
Lymphoma (146)
Machine learning (5)
Management (58)
Manufacturing (294)
MASH (64)
Medical device (13448)
Medtech (13453)
Mergers & acquisitions (19463)
Metabolic disorders (667)
Multiple sclerosis (77)
NASH (16)
Neurodegenerative disease (83)
Neuropsychiatric disorders (27)
Neuroscience (1886)
NextGen: Class of 2025 (6524)
Non-profit (4482)
Northern California (2580)
Now hiring (39)
Obesity (358)
Opinion (204)
Ovarian cancer (73)
Pain (84)
Pancreatic cancer (81)
Parkinson's disease (146)
Partnered (21)
Patents (227)
Patient recruitment (104)
Peanut (46)
People (57335)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20528)
Phase II (29033)
Phase III (21633)
Pipeline (1133)
Policy (133)
Postmarket research (2563)
Preclinical (8688)
Press Release (64)
Prostate cancer (100)
Psychedelics (30)
Radiopharmaceuticals (245)
Rare diseases (373)
Real estate (5913)
Recruiting (65)
Regulatory (22255)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (66)
Series A (127)
Series B (83)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2217)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3581)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (32)
The Weekly (28)
United States (22387)
Vaccines (672)
Venture capitalists (41)
Weight loss (231)
Women's health (35)
Worklife (15)
Date
Today (211)
Last 7 days (557)
Last 30 days (2465)
Last 365 days (32824)
2025 (9735)
2024 (35241)
2023 (40108)
2022 (51208)
2021 (55753)
2020 (54131)
2019 (46604)
2018 (35088)
2017 (32186)
2016 (31561)
2015 (37643)
2014 (31385)
2013 (26409)
2012 (28656)
2011 (29310)
2010 (27375)
Location
Africa (726)
Alabama (53)
Alaska (7)
Arizona (230)
Arkansas (13)
Asia (37879)
Australia (6190)
California (5897)
Canada (1964)
China (500)
Colorado (259)
Connecticut (265)
Delaware (138)
Europe (81313)
Florida (875)
Georgia (203)
Idaho (57)
Illinois (518)
India (25)
Indiana (305)
Iowa (10)
Japan (157)
Kansas (102)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (869)
Massachusetts (4403)
Michigan (219)
Minnesota (384)
Mississippi (2)
Missouri (80)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1676)
New Mexico (28)
New York (1684)
North Carolina (950)
North Dakota (7)
Northern California (2580)
Ohio (199)
Oklahoma (14)
Oregon (34)
Pennsylvania (1329)
Puerto Rico (11)
Rhode Island (32)
South America (1099)
South Carolina (21)
South Dakota (1)
Southern California (2217)
Tennessee (101)
Texas (879)
Utah (174)
Virginia (141)
Washington D.C. (61)
Washington State (541)
West Virginia (3)
Wisconsin (52)
698,963 Results for "centinel spine inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Over 10,000 Procedures Completed in U.S. with Centinel Spine’s Match-the-Disc™ prodisc® Cervical Total Disc Replacement System
February 12, 2025
·
3 min read
Press Releases
Centinel Spine® prodisc® Total Disc Replacement Grows 38% in Full-year 2024, Setting New Revenue Record in Fourth Quarter
January 23, 2025
·
5 min read
Business
Centinel Spine® Hits Another Revenue Record in First Quarter 2024 as prodisc® Total Disc Replacement Worldwide Growth Momentum Continues
Centinel Spine®, LLC announced achievement of record revenue in the first quarter of 2024—outperforming Q4 2023, its previous record quarter.
April 23, 2024
·
3 min read
Pharm Country
Centinel Spine® to Sponsor Major Worldwide Live Webinar Symposium on Cervical Disc Arthroplasty
Centinel Spine®, LLC (“the Company”) today announced that it will sponsor an upcoming major worldwide live webinar symposium on the current state of TDR options for patients with chronic cervical disc disease.
March 21, 2024
·
3 min read
Pharm Country
Centinel Spine® Completes Divestment of its Spine Fusion Business to Silony Spine
Centinel Spine®, LLC announced that it has completed the previously announced agreement to sell its global spine fusion product portfolio and related assets to Silony Spine.
October 19, 2023
·
2 min read
Press Releases
Landmark Lumbar Total Disc Replacement Study of Nearly 1,200 Patients Supports Long-term Clinical Success and Durability of Centinel Spine’s prodisc® L System
December 13, 2024
·
5 min read
Press Releases
Centinel Spine® Announces Record Revenue in Third Quarter 2024 as prodisc® Total Disc Replacement Growth Accelerates
October 18, 2024
·
3 min read
Business
Centinel Spine® Concludes Transformative Year with Record prodisc® Total Disc Replacement Revenue and Growth in December and Fourth Quarter 2023
Centinel Spine®, LLC today reported year-end 2023 business results and the foundation for accelerated growth in 2024.
January 18, 2024
·
5 min read
Pharm Country
Coverage Expansion Continues for One- and Two-level Lumbar Total Disc Replacement as the Top Commercial Payer in Tennessee Establishes Positive Coverage for Centinel Spine’s prodisc® L
Centinel Spine®, LLC (“the Company”) today announced significant expansion of coverage for lumbar TDR procedures in Tennessee.
February 21, 2024
·
3 min read
Pharm Country
Centinel Spine® Record prodisc® Total Disc Replacement Growth of 55% in 2023 Sets the Foundation for Continued Growth in 2024 and Beyond
Centinel Spine®, LLC announced achievement of record full-year 2023 TDR business results, setting the stage for continued accelerated growth in 2024.
January 31, 2024
·
6 min read
1 of 69,897
Next
